MediWound (MDWD) Projected to Post Earnings on Wednesday

MediWound (NASDAQ:MDWD) will likely be releasing its earnings data before the market opens on Wednesday, March 19th. Analysts expect MediWound to post earnings of ($0.61) per share and revenue of $5.79 million for the quarter. Persons interested in participating in the company’s earnings conference call can do so using this link.

MediWound Trading Up 3.7 %

Shares of NASDAQ:MDWD opened at $17.21 on Wednesday. The firm has a market cap of $185.63 million, a price-to-earnings ratio of -5.93 and a beta of 0.82. The stock’s 50-day moving average price is $18.02 and its two-hundred day moving average price is $17.60. MediWound has a 12-month low of $12.78 and a 12-month high of $24.00.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on MDWD shares. HC Wainwright restated a “buy” rating and issued a $25.00 target price on shares of MediWound in a report on Friday, January 10th. Craig Hallum initiated coverage on shares of MediWound in a report on Friday, February 28th. They issued a “buy” rating and a $39.00 price target on the stock.

About MediWound

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in United States, Europe, and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units.